Læknablaðið - 01.06.1969, Side 29

LÆKNABLAÐIÐ
83
amphenicol. Clin. Proc. Cliildren’s Hosp. Wash. D. C. 17 :171. Til-
vitnun í ref. 10.
10. Yunis, A. A., Bloomberg, G. R. (1964): Chloramphenicol toxicity:
Clinical features and Patliogenesis. í Progress in Hematology; Grune
& Stratton.
11. Saidi, P., Wallerstein, R. O., Aggeler, P. M. (1961): Effect of clilor-
amphenicol on erythropoiesis. J. Lab. Clin. Med. 57 :247.
12. Rubin, D. et al. (1958): Changes in iron metabolism in early chlor-
amphenicol toxicity. J. Clin. Invest. 37 :1286.
13. Gussoff, B. D., Lee, S. L., Lichtman, H. C. (1962): Erytliropoietic
changes during therapy with chloramphenicol. Arch. Int. Mcd. 109 :
176.
14. Cone, T. E., Jr., Abelson, S. M. (1952): Aplastic anemia following
trwo days of chloramphenicol therapy, J. Pediatrics 41 :340. Til-
vitnun i ref. 7.
15. JiJi, R. M., Gangarosa, E. J., de la Macorra, F. (1963): Chlorampheni-
col and its sulfamoyl analogues. Report of reversible erythrpoietie
toxicity in healthy volunteers. Arch. Int. Med. 111 :70.
16. Suhrland, L. G., Weisberger, A. S. (1963): Chloramphenicol toxicity
in liver and renal disease. Arch. Int. Med. 112 : 747.
17. McCurdy, P. R. (1963): Plasma concentration of chloramphenicol
and bone marrow suppression. Blood 21 : 363.
18. Yunis, A. A., Arimura, G. K.: Biochemical predisposition to chlor-
amphenicol induced bone marrow aplasia. Clin. Res., April 1963.
Tilvitnun í 10.
19. Lewis S. M. (1965): Course and prognosis in Aplastic Anaemia.
Brit. M. J. 1: 1027.